The Wellcome Trust Sanger Institute responds to the Life Sciences Industrial Strategy

The Life Sciences Industrial Strategy recognises the key role genomics and genetics will play in future healthcare provision

The Wellcome Trust Sanger Institute responds to the Life Sciences Industrial Strategy

The report, written by Life Science’s Champion Professor Sir John Bell, provides recommendations to government on the long-term success of the life sciences sector.

Below Dr Julia Wilson gives the Wellcome Trust Sanger Institute's response.

Julia Wilson, Associate Director, Sanger InstituteGenome Research Limited
Julia Wilson, Associate Director, Sanger Institute

“The Wellcome Trust Sanger Institute welcomes the release of the Life Sciences: Industrial Strategy, which recognises that genomics, data and research are the key to realising transformative health care in the UK. The Sanger Institute has been at the cutting edge of world-leading genomic research for nearly 25 years, and continues to create the foundation for new genomic technologies for healthcare.

This Life Science Strategy offers a framework for UK research to support and deliver a world-leading healthcare system. We welcome the recommendations for creating a Health Advanced Research Programme, and to support that we encourage the government to implement the recommendations made by this Institute and Dame Sally Davies in her recent report, Generation Genome.

The Sanger Institute remains committed to powering the genomic revolution.”

Dr Julia Wilson, associate director of the Wellcome Trust Sanger Institute

Notes to Editors

Publications:

Life sciences: industrial strategy

The report, written by Life Science’s Champion Professor Sir John Bell, provides recommendations to government on the long-term success of the life sciences sector.

Chief Medical Officer annual report 2016: Generation Genome

Professor Dame Sally Davies’s eighth independent report to government as CMO looks at how genomics can improve health and prevent ill-health

Sanger Institute response to Genome Generation Report

The UK Chief Medical Officer's report has highlighted the key role genomics and genetics will play in future healthcare provision. Associate director Dr Julia Wilson and honorary faculty member Professor Sharon Peacock comment

Selected Websites
Contact the Press Office

Emily Mobley, Media Manager

Tel +44 (0)1223 496 851

Dr Samantha Wynne, Media Officer

Tel +44 (0)1223 492 368

Dr Matthew Midgley, Media Officer

Tel +44 (0)1223 494 856

Wellcome Sanger Institute,
Hinxton,
Cambridgeshire,
CB10 1SA,
UK

Mobile +44 (0) 7748 379849

Recent News

Salmonella responsible for bloodstream infections in central Africa resistant to nearly all drugs
Strain of dangerous pathogen shown to have developed resistance to last-line-of-defence drug
Babies' gut bacteria affected by delivery method, Baby Biome project shows
Vaginal delivery promotes mother's gut bacteria in baby's gut
500,000 whole human genomes will be a game-changer for research into human diseases
Following on from a successful pilot at the Sanger Institute, we are leading a project to sequence the genomes of all UK Biobank volunteers to power the next wave of genetic and health research